These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4449032)

  • 1. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

  • 3. A new sustained-release tablet formulation of procainamide.
    Fremstad D; Dahl S; Jacobsen S; Lunde PK; Nådland KJ; Marthinsen AA; Waaler T; Landmark KH
    Eur J Clin Pharmacol; 1973 Dec; 6(4):251-5. PubMed ID: 4591152
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic of procainamide in man.
    Koch-Weser J
    Ann N Y Acad Sci; 1971 Jul; 179():370-82. PubMed ID: 5285382
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical application of the pharmacokinetics of procaine amide.
    Koch-Weser J
    Cardiovasc Clin; 1974; 6(2):63-75. PubMed ID: 4613464
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Dose intervals for procainamide.
    Reidenberg MM
    Lancet; 1975 Jun; 1(7922):1429-30. PubMed ID: 49596
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
    Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
    Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of plasma levels in evaluation of procainamide dosage.
    Shaw TR; Kumana CR; Royds RB; Padgham CM; Hamer J
    Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893
    [No Abstract]   [Full Text] [Related]  

  • 10. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.
    Karlsson E; Kinman A; Sonnhag C
    Eur J Clin Pharmacol; 1977; 11(1):1-6. PubMed ID: 832652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 15. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P; Laursen HB; Christiansen BD; Moller J
    Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arrhythmia prophylaxis with procanamide: inadequate dosage?].
    Collste P; Karlsson E; Norlander B; Sievers J; Sjöqvist F
    Lakartidningen; 1972 Jun; 69():Suppl 2:47-50. PubMed ID: 4645697
    [No Abstract]   [Full Text] [Related]  

  • 18. Canine electrocardiographic and cardiac electrophysiologic changes induced by procainamide.
    Rosen MR; Gelband H; Hoffman BF
    Circulation; 1972 Sep; 46(3):528-36. PubMed ID: 5071738
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of procainamide therapy after cardiac infarction.
    Royds R; Shaw TR; Kumana CR; Padgham D; Hamer J
    Br Heart J; 1973 Aug; 35(8):862-3. PubMed ID: 4729848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.